Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Myeloma-specific superenhancers affect genes of biological and clinical relevance in myeloma

12 Feb 2021

Abstract excerpt

Multiple myeloma (MM) is an aggressive plasma cell neoplasm characterized by genomic heterogeneity. Superenhancers (SEs) are defined as large clusters of enhancers in close genomic proximity, which regulate genes for maintaining cellular identity and promote oncogenic transcription to which cancer cells highly addicted. Here, we analyzed cis-regulatory elements in MM samples with H3K27ac ChIP-seq, to identify...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Multiple Myeloma Research and Treatments
Share to Protein Degradation and Inhibitors
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33579893
DOI: 10.1038/s41408-021-00421-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Myeloma-specific superenhancers affect genes of biological and clinical relevance in myelomaPMID 33579893Read ↗

Chromatin-based, in cis and in trans regulatory rewiring underpins distinct oncogenic transcriptomes in multiple myelomaSemantic proximity Read ↗

The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myelomaSemantic proximity Read ↗

Selective Enhancer Gain-of-Function Deregulates MYC Expression in Multiple MyelomaSemantic proximity Read ↗

Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myelomaSemantic proximity Read ↗

Active enhancer and chromatin accessibility landscapes chart the regulatory network of primary multiple myelomaSemantic proximity Read ↗

Whole-genome sequencing of multiple myeloma reveals oncogenic pathways are targeted somatically through multiple mechanisms.Semantic proximity Read ↗

Dynamic super-enhancer core regulatory circuits and epigenetic landscapes drive malignant progression and refractory disease in multiple myelomaSemantic proximity Read ↗

Functional dissection of inherited non-coding variation influencing multiple myeloma risk.Semantic proximity Read ↗

DNA Methylation Analysis Determines the High Frequency of Genic Hypomethylation and Low Frequency of Hypermethylation Events in Plasma Cell TumorsSemantic proximity Read ↗

DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple myeloma.Semantic proximity Read ↗

Mapping Disease Transitions from Premalignant, Asymptomatic to Advanced Myeloma through Integrative Epigenomic and Transcriptional AnalysesSemantic proximity Read ↗

Methylation variability and LINE-1 activation in multiple myelomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.